BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution form – ET HealthWorld | Pharma

BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution form – ET HealthWorld | Pharma
New Delhi: BDR Pharmaceuticals on Tuesday said it has introduced Enzalutamide oral solution for treatment of prostate cancer, claiming to ...
Read more

US FDA approvals bounce back in 2023, sparking hopes of a biotech recovery – ET HealthWorld | Pharma

US FDA approvals bounce back in 2023, sparking hopes of a biotech recovery – ET HealthWorld | Pharma
Bengaluru: The US Food and Drug Administration approved nearly 50 per cent more novel drugs in 2023 than in 2022, ...
Read more

AstraZeneca India launches Trastuzumab deruxtecan for HER-2 positive metastatic breast cancer – ET HealthWorld | Pharma

AstraZeneca India launches Trastuzumab deruxtecan for HER-2 positive metastatic breast cancer – ET HealthWorld | Pharma
Chennai: AstraZeneca India Pharma Ltd officially launched Trastuzumab deruxtecan, therapy tailored for the treatment of adult patients with unresectable or ...
Read more

Glenmark launches biosimilar of anti-diabetic drug Liraglutide in India – ET HealthWorld | Pharma

Glenmark launches biosimilar of anti-diabetic drug Liraglutide in India – ET HealthWorld | Pharma
Mumbai: Glenmark Pharmaceuticals Ltd has launched a biosimilar of the anti-diabetic drug Liraglutide for the first time in India, The ...
Read more

Novartis signs gene therapy deal with Voyager for $100 mln upfront – ET HealthWorld | Pharma

Novartis signs gene therapy deal with Voyager for 0 mln upfront – ET HealthWorld | Pharma
Bangalore: Voyager Therapeutics said on Tuesday Swiss-based drugmaker novartis would pay $100 million upfront as part of a licensing deal ...
Read more

Novartis signs gene therapy deal with Voyager for $100 mln upfront – ET HealthWorld | Pharma

Novartis signs gene therapy deal with Voyager for 0 mln upfront – ET HealthWorld | Pharma
Bangalore: Voyager Therapeutics said on Tuesday Swiss-based drugmaker novartis would pay $100 million upfront as part of a licensing deal ...
Read more

Cell and gene therapy to have greatest impact on pharmaceutical industry in 2024: GlobalData – ET HealthWorld | Pharma

Cell and gene therapy to have greatest impact on pharmaceutical industry in 2024: GlobalData – ET HealthWorld | Pharma
London: Healthcare industry professionals scored cell and gene therapy (CGT) as the industry trend to have the greatest impact on ...
Read more

2023 has been pivotal for JB Pharma: Nikhil Chopra – ET HealthWorld | Pharma

2023 has been pivotal for JB Pharma: Nikhil Chopra – ET HealthWorld | Pharma
New Delhi : Nikhil ChopraCEO & Whole Time Director, JB Pharma spoke to ETHealthworld’s Prathiba Raju about how 2023 has ...
Read more

IIL to invest Rs 700 crore on it greenfield veterinary vaccine facility in Hyderabad’s Genome Valley – ET HealthWorld | Pharma

IIL to invest Rs 700 crore on it greenfield veterinary vaccine facility in Hyderabad’s Genome Valley – ET HealthWorld | Pharma
Hyderabad: Indian Immunologicals Limited ,IIL) on Thursday announced that it has started construction of its new greenfield veterinary vaccine facility ...
Read more

US FDA places clinical hold on Iovance’s lung cancer treatment trial – ET HealthWorld | Pharma

US FDA places clinical hold on Iovance’s lung cancer treatment trial – ET HealthWorld | Pharma
New Delhi: The US Food and Drug Administration has placed a clinical hold on iovance Biotherapeutics’ lung cancer therapy trial ...
Read more
123 Next